Collage photo of Pierre Blanchard and Cedric Pobel
Sep 18, 2024, 16:38
Pierre Blanchard: The molecular analysis of the PEACE 1 trial
Pierre Blanchard, Radiation Oncology Clinical section chief at Gustave Roussy Cancer Institute, shared on X:
“Dr Pobel at ESMO2024 presenting the molecular analysis of the PEACE 1 trial. Identifies molecular phenotypes and prognostic markers but no interaction with abiraterone efficacy Major undertaking by GETUG, Gustave Roussy.”
Source: Pierre Blanchard/X
More posts featuring ESMO24 on oncodaily.com
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 19:09
Apr 1, 2025, 18:48
Apr 1, 2025, 18:37
Apr 1, 2025, 18:26
Apr 1, 2025, 18:22